155 related articles for article (PubMed ID: 22718290)
1. Antimicrobial effects of Burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa.
Hyo Y; Yamada S; Ishimatsu M; Fukutsuji K; Harada T
Med Mol Morphol; 2012 Jun; 45(2):66-71. PubMed ID: 22718290
[TBL] [Abstract][Full Text] [Related]
2. Comparative antibacterial activity of topical antiseptic eardrops against methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Youn CK; Jang SJ; Jo ER; Choi JA; Sim JH; Cho SI
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():80-3. PubMed ID: 27240501
[TBL] [Abstract][Full Text] [Related]
3. Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea.
Jinnouchi O; Kuwahara T; Ishida S; Okano Y; Kasei Y; Kunitomo K; Takeda N
Auris Nasus Larynx; 2012 Aug; 39(4):374-7. PubMed ID: 21862264
[TBL] [Abstract][Full Text] [Related]
4. The antibacterial activity of acetic acid and Burow's solution as topical otological preparations.
Thorp MA; Kruger J; Oliver S; Nilssen EL; Prescott CA
J Laryngol Otol; 1998 Oct; 112(10):925-8. PubMed ID: 10211213
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of Burow's solution as an ear preparation for the treatment of chronic ear infections.
Kashiwamura M; Chida E; Matsumura M; Nakamaru Y; Suda N; Terayama Y; Fukuda S
Otol Neurotol; 2004 Jan; 25(1):9-13. PubMed ID: 14724484
[TBL] [Abstract][Full Text] [Related]
6. [Pharmaceutical and pharmacological evaluation of Burow's solution (aluminum acetate solution), hospital preparation, and development of its rapid preparation method].
Ishibashi Y; Murakami T; Yumoto R; Sakai M; Shintani H; Itaha H; Kanbe M; Masuda S; Yajin K; Kihira K; Takano M
Yakugaku Zasshi; 2004 Nov; 124(11):833-40. PubMed ID: 15516810
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacies of topical antiseptic eardrops against biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Youn CK; Jun Y; Jo ER; Jang SJ; Song H; Cho SI
J Laryngol Otol; 2018 Jun; 132(6):519-522. PubMed ID: 29909794
[TBL] [Abstract][Full Text] [Related]
8. Use of a modified Burow's solution to treat canine otitis externa: A randomised comparative clinical study.
Sadeghi S; Kamrani A; Kuc U; Polissar N; Selukar S; Sadeghi S
Vet Rec; 2022 Feb; 190(3):e503. PubMed ID: 34091924
[TBL] [Abstract][Full Text] [Related]
9. Morphological bactericidal fast-acting effects of peracetic acid, a high-level disinfectant, against
Chino T; Nukui Y; Morishita Y; Moriya K
Antimicrob Resist Infect Control; 2017; 6():122. PubMed ID: 29214017
[TBL] [Abstract][Full Text] [Related]
10. Burow's solution in the treatment of active mucosal chronic suppurative otitis media: determining an effective dilution.
Thorp MA; Gardiner IB; Prescott CA
J Laryngol Otol; 2000 Jun; 114(6):432-6. PubMed ID: 10962675
[TBL] [Abstract][Full Text] [Related]
11. [Burow's solution treatment for external auditory canal and mastoid cavity cholesteatoma].
Terayama Y; Sakata A; Murata Y; Harada K; Ohashi M
Nihon Jibiinkoka Gakkai Kaiho; 2010 Jun; 113(6):549-55. PubMed ID: 20653194
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of biogenic selenium nanoparticles with antimicrobial properties made by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa.
Medina Cruz D; Mi G; Webster TJ
J Biomed Mater Res A; 2018 May; 106(5):1400-1412. PubMed ID: 29356322
[TBL] [Abstract][Full Text] [Related]
13. Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil.
Bouhdid S; Abrini J; Zhiri A; Espuny MJ; Manresa A
J Appl Microbiol; 2009 May; 106(5):1558-68. PubMed ID: 19226402
[TBL] [Abstract][Full Text] [Related]
14. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus.
Hincapié O; Giraldo P; Orduz S
Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cell-wall damage mediated, antibacterial activity of core-shell ZnO@Ag heterojunction nanorods against Staphylococcus aureus and Pseudomonas aeruginosa.
Ponnuvelu DV; Suriyaraj SP; Vijayaraghavan T; Selvakumar R; Pullithadathail B
J Mater Sci Mater Med; 2015 Jul; 26(7):204. PubMed ID: 26152512
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural alterations of bacteria during the postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Kolka R; Gudmundsson A; Gudmundsson S
Chemotherapy; 1993; 39(3):153-62. PubMed ID: 8508685
[TBL] [Abstract][Full Text] [Related]
17. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study.
Gayani B; Dilhari A; Wijesinghe GK; Kumarage S; Abayaweera G; Samarakoon SR; Perera IC; Kottegoda N; Weerasekera MM
Microbiologyopen; 2019 May; 8(5):e00723. PubMed ID: 30221843
[TBL] [Abstract][Full Text] [Related]
18. Preparation, Characterization, and Evaluation of Zinc Oxide Nanoparticles Suspension as an Antimicrobial Media for Daily Use Soft Contact Lenses.
Shayani Rad M; Sabeti Z; Mohajeri SA; Fazly Bazzaz BS
Curr Eye Res; 2020 Aug; 45(8):931-939. PubMed ID: 31847595
[TBL] [Abstract][Full Text] [Related]
19. Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil.
Bouhdid S; Abrini J; Amensour M; Zhiri A; Espuny MJ; Manresa A
J Appl Microbiol; 2010 Oct; 109(4):1139-49. PubMed ID: 20456525
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2.
Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC
Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
